Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 960-964

  Bekkering, Frank C ^a   Brouwer, Johannes T ^a   Leroux Roels, Geert ^b   Van Vlierberghe, Hans ^b   Elewaut, Andre ^b   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Hepatitis C; Interferon alpha 2b; Polymerase chain reaction; Viral kinetics

Indexed keywords

ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0032102892     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80343-7     Document Type: Article

References (10)

1. Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. J Hepatol. 28:1998;951-959.
2. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 24:1996;778-789.
3. Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: a meta-analysis of individual European patients. J Hepatol. 26:1997;961-966.
4. Orito E, Mizokami M, Suzuki K, Ohba K, Ohna T, Mori M, et al. Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol. 46:1995;109-115.
5. Tong MJ, Hwang S, Lefkowitz M, Lee S, Co RL, Conrad A, et al. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J Gastroenterol Hepatol. 9:1994;587-591.
6. Damen M, Cuypers HT, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, et al. International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods. 58:1996;175-185.
7. Zeuzem S, Schmidt JM, Lee JH, Ruster B, Roth WK. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology. 23:1996;366-371.
8. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha. Hepatology. 26:1997;226-231.
9. National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C Hepatology. 26:1997;2-10. (Suppl 1).
10. Yasui K, Okanoue T, Murakami Y, Itoh Y, Minami M, Sakamoto S. Dynamics of hepatitis C viremia after interferon therapy. Hepatology. 24:1996;160A.